Price
$0.60Social Signal Score
52-week range
- Last close
- $0.60
- Off 52w high
- -26.3%
- 200-day average
- $0.49
- vs 200-day
- +21.5%
Revenue
$9.09M+20.66%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Derek Cassell
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Employees
- 91
- Beta
- 0.67
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -8.09
Financials
Revenue
$9.09M+20.7%Net Income
$22.44MEBITDA
$1.46MFree Cash Flow
$975.1KEPS (diluted)
$0.68Shares Outstanding (diluted)
32.34M+213.0%Operating Expenses
$3.75MCash & Debt
$8.39MReturn of Capital
$0.00Revenue by Segment (annual)
$35.22MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $35.22M | $-1.88M | $-0.16 |
| 2024 | $36.89M | $-3.08M | $-0.26 |
| 2023 | $34.48M | $-3.39M | $-0.29 |
| 2022 | $36.97M | $-7.39M | $-0.64 |
| 2021 | $39.66M | $3.44M | $0.30 |
| 2020 | $33.88M | $-118.6K | $-0.01 |
| 2019 | $34.02M | $-2.56M | $-0.23 |
| 2018 | $30.57M | $-5.43M | $-0.51 |
| 2017 | $29.73M | $-4.73M | $-0.45 |
| 2016 | $27.19M | $-8.50M | $-0.83 |
| 2015 | $20.79M | $-5.67M | $-0.56 |
| 2014 | $12.26M | $-8.75M | $-0.88 |
| 2013 | $15.64M | $-17.92M | $-3.71 |
| 2012 | $19.79M | $-17.46M | $-6.38 |
Valuation
TRCKhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70+200.00%Social Signal Score
Mentions (73)
- Newsfool.com·14h ago·Positive
Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy? Johnson & Johnson is a leader in the pharmaceutical and medical device sectors. JNJ is a Dividend King with an above-market yield.
View source ↗ - News247wallst.com·3d ago·Negative
2 Newer Monthly Paycheck ETFs vs. a Veteran: Does a Short Track Record Matter? A monthly check looks reliable until you ask which markets it has actually survived. Two young income ETFs and a 2003 veteran reveal what a payment history hides, and the answer may change how retirees read every distribution table.
View source ↗ - Newsmarketbeat.com·5d ago·Negative
Solid Biosciences Eyes FDA Fast-Track Path for Duchenne Gene Therapy, Potential 2027 Filing Solid Biosciences NASDAQ: SLDB plans to meet with the U.S. Food and Drug Administration before the end of 2026 to discuss a potential accelerated approval pathway for its Duchenne muscular dystrophy gene therapy, CEO Bo Cumbo said at a Jefferies fireside chat.
View source ↗ - Newsglobenewswire.com·10d ago·Neutral
Beamr Issues Q3-2026 CEO Letter: On Track to Deliver 50% Revenue Growth in 2026 Expected revenue increase comes from existing customer agreements, renewals and broader business activities, including a three-year renewal with a major global streaming platform In autonomous vehicles, where customers process data at petabyte scale, even a small number of production customers could have a substantial impact on Beamr's future revenues Herzliya, Israel, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Beamr Imaging
View source ↗ - Newsglobenewswire.com·12d ago·Neutral
Fairmount Park Casino and Racing Announces Facility Improvements, New Racing Schedule for 2027 Track Boasts Record Numbers During 2026, Builds on Momentum for Future Track Boasts Record Numbers During 2026, Builds on Momentum for Future
View source ↗ - Newsseekingalpha.com·13d ago·Neutral
Ares Capital: Performance Back On Track Ares Capital (ARCC) delivered a 2.3% NAV return in Q3, its strongest in the past year. ARCC's acquisition of MFIC adds significant portfolio diversification and is expected to be modestly accretive to core earnings. Dividend yield stands at 10% with coverage below 100%, however rising NII and a large spillover support dividend stability.
View source ↗ - Newsseekingalpha.com·16d ago·Positive
Royce Micro-Cap Trust: A 7% Yield And A Track Record Worth Paying For Royce Micro-Cap Trust offers a nearly 7% annualized distribution yield, providing shareholders with regular quarterly payments. RMT has beaten its small-cap benchmarks over the past 5 and 10 years, even after management fees. Nearly all distributions over the past five years came from income and realized gains, with very little return of capital.
View source ↗ - Newsseekingalpha.com·17d ago·Neutral
Vishay Intertechnology Still On Track, But The Sector Has Cooled Vishay Intertechnology delivered strong Q3 results, beating expectations on revenue, margins, and free cash flow despite sector-wide sentiment headwinds. VSH is ahead of schedule on its margin improvement targets, with gross margin at 25.5% and operating income up 72% sequentially. The Vishay 3.0 strategy is driving growth in industrial, automotive, and AI-related markets, though capacity expansion delays push some of the benefits
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
B2Gold Reports Q3 2026 Results - Lowers Annual All-In Sustaining Cost Guidance and Remains On-Track to Achieve Production Guidance VANCOUVER, British Columbia, Nov. 04, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce its operational and financial results for the third quarter of 2026. All dollar figures are in United States dollars unless otherwise indicated. The consolidated financial statements and Management Dis
View source ↗ - Newsglobenewswire.com·18d ago·Positive
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile WAKIX ® Net Revenue in Q3 of $269 Million; Driven by Strong Demand with 400 Net Patient Adds in the Quarter; Reiterates Full Year Guidance of $1.0B to $1.04B
View source ↗ - Newsseekingalpha.com·18d ago·Neutral
Amazon: AWS Is On Track To Outperform Today's Entire Company By 2028 Amazon (AMZN) delivered record operating profit, yet shares dipped on negative free cash flow and a shift from net cash to net debt. AWS is projected to out-earn Amazon's current total operating income by 2028, with robust contract-backed growth and high margins. Short-term risks include surging capital expenditures, rising debt, and negative free cash flow through at least 2028, limiting buybacks and valuation via FCF.
View source ↗ - Newsseekingalpha.com·19d ago·Neutral
Can Q3 Earnings Get Back On Track After Being Rattled By Big Tech's AI Prints? Heavy AI capex hit free cash flows at Alphabet and Meta, while Microsoft and Amazon faced mounting concerns over compressed margins, search cannibalization, and agentic commerce disruption. With Apple reporting on an unusual Monday schedule, nine S&P 500 firms confirmed delayed reporting dates, a historical indicator of potential bad news ahead. This marks the second week of Q3 earnings season, with 2,465 companies ex
View source ↗ - Newsprnewswire.com·20d ago·Neutral
i-80 Gold Reports Third Quarter 2026 Results; Archimedes Underground on Track to Begin Production Mining by Year-End TORONTO, Nov. 2, 2026 /PRNewswire/ -- i-80 GOLD CORP. (NYSE:IAUX) (TSX:IAU) ("i-80 Gold" or the "Company") reports its financial and operating results, as well as development highlights, for the three and nine months ended September 30, 2026.
View source ↗ - Newsseekingalpha.com·22d ago·Positive
Darling Ingredients: Back On Track, With More To Prove Darling Ingredients remains a buy, as profitability, debt reduction, and attractive valuation support further upside despite a 71% rally in the past year. Turnaround at Diamond Green Diesel has driven results, but I seek more balanced contributions from Feed and Food segments for long-term stability. Management targets $2.2–$2.3 billion in 2026 combined adjusted EBITDA and net debt below $3 billion, emphasizing debt reduction over aggressive
View source ↗ - Newsglobenewswire.com·23d ago·Neutral
Moleculin Completes Dosing Patients in Part A of Pivotal MIRACLE Trial; Comprehensive Data Readout on Track for Q1 2027 Milestone underscores execution of pivotal Phase 2/3 trial evaluating Annamycin in combination with cytarabine for relapsed or refractory acute myeloid leukemia (AML)
View source ↗ - Newsfool.com·23d ago·Negative
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within 2 to 3 Years. As Anthropic Prepares for Its $2 Trillion IPO, Is That Timeline Still on Track? Anthropic is going public, and management is making bold claims about AI's capabilities. About two years ago, Anthropic founder Dario Amodei said that AI might surpass human capabilities within two to three years.
View source ↗ - Newswsj.com·25d ago·Neutral
Deutsche Bank on Track to Reach 2026 Goals After Earnings, Revenue Rise The German bank reported an increase in third-quarter profit and revenue, and said it was on track for its full-year targets.
View source ↗ - Newsseekingalpha.com·26d ago·Neutral
Northeast Bank's Strong Track Record Should Continue Northeast Bank remains a Buy as strong growth, solid asset quality, and attractive earnings valuation outweigh premium book multiples and minor credit concerns. NBN's net interest income rose from $48.6M to $58.1M, with net income up to $5.4M, driven by loan and deposit growth despite a slight margin compression. High-cost brokered deposits now continue to climb, but uninsured deposits are minimal at 4.1% based on 2026 figures, mitigating liqu
View source ↗ - Newsseekingalpha.com·26d ago·Neutral
QDVO: Tech-Heavy Covered Call ETF, Outstanding Distribution Yield And Track-Record The Amplify CWP Growth & Income ETF is a covered call growth equity ETF. Its equity portfolio provides investors with solid upside potential, while its covered calls boost its distribution yield to 10.8%. Lots of income investors are underweight in tech, and the fund seems like a particularly compelling investment for these investors.
View source ↗ - Newsprnewswire.com·31d ago·Neutral
PG&E Corporation Reports Third Quarter 2026 Results; On Track to Deliver Solid 2026; Reaffirms 2026 and 2027 Guidance OAKLAND, Calif., Oct. 22, 2026 /PRNewswire/ -- PG&E Corporation (NYSE: PCG) is on track to deliver solid financial results in 2026.
View source ↗ - Newsmarketbeat.com·32d ago·Positive
Hochschild Mining Stays on Track as Mara Rosa Turnaround Gains Momentum Hochschild Mining LON: HOC said it remained on track to meet its full-year production and cost guidance after reporting what Chief Executive Officer Eduardo Landín described as a strong operational performance in the third quarter of 2026.
View source ↗ - Newsfool.com·33d ago·Neutral
SpaceX Revenue Projections Look Wildly Optimistic Based on Elon Musk's Forecasting Track Record Musk thinks SpaceX will achieve $3.5 trillion in annual revenue sometime around 2033. The CEO is an impressive innovator, but he has a history of making bold projections that prove inaccurate.
View source ↗ - Newsbusinesswire.com·33d ago·Neutral
SOAR AI's Ohio AI Compute Campus on Track for December 31 In-Service Date, with Contracted Revenue Expected to Begin January 2027 NORTH CANTON, Ohio--(BUSINESS WIRE)--SOAR AI, Inc. (NYSE American: SOAR), formerly known as Volato Group, Inc. (“SOAR AI” or the “Company”), today provided a construction update on its AI compute campus in Chillicothe, Ohio. Low-voltage data hall transformers and cooling plant equipment are being installed this week, and the Company remains on schedule to place its fi
View source ↗ - Newsfool.com·34d ago·Negative
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within Two to Three Years. With Anthropic Now Filing for a $2 Trillion IPO, Is That Timeline Still on Track? Anthropic has passed OpenAI by most reasonable measurements as the leading AI lab. Nvidia CEO Jensen Huang has said we've already reached artificial general intelligence.
View source ↗ - Newsseekingalpha.com·37d ago·Positive
The Chefs' Warehouse: A Strong Track Record Of EPS Beats The Chefs' Warehouse remains a BUY as strong 3Q26 results are expected from robust operating leverage and resilient fine dining demand. CHEF's premium valuation at 17.3x forward EV/EBITDA is justified by forward EBITDA growth double that of peers and consistent earnings beats. A record free cash flow and a reduced net leverage ratio support increased share repurchases, adding further upside potential.
View source ↗ - Newsglobenewswire.com·39d ago·Negative
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome – Company on track to initiate first-ever formal clinical trial in Peeling Skin Syndrome before year end – Orphan Drug designation milestone provides 10 years of market exclusivity for Peeling Skin Syndrome in Europe after receipt of marketing authorization in the European Union – Designation Represents Eighth Important Regulatory Milestone for QRX
View source ↗ - Newsprnewswire.com·39d ago·Neutral
i-80 Gold Provides a Development Update; Archimedes Underground and Lone Tree Plant Refurbishment Remain on Track and Mineral Point Open Pit Prioritized in Updated Development Plan All amounts are expressed in United States dollars unless otherwise stated. TORONTO, Oct. 14, 2026 /PRNewswire/ -- i-80 GOLD CORP.
View source ↗ - Newsprnewswire.com·40d ago·Neutral
XTI Aerospace Announces Completion of Internal Review; On Track to File Quarterly Report on Form 10-Q By October 26, 2026 Provides Preliminary Second Quarter Results and Update on 2026 Guidance DALLAS, Oct. 13, 2026 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace," "XTI" or the "Company"), an aerospace and advanced technology platform and parent company of Drone Nerds, LLC ("Drone Nerds"), a leading drone solutions platform serving commercial, enterprise and government custome
View source ↗ - Newsglobenewswire.com·45d ago·Negative
Perspective Therapeutics Granted Fast Track Designation for [212Pb]PSV359 for the Treatment of Adult Patients with Locally Advanced Unresectable and/or Metastatic FAP-Positive Solitary Fibrous Tumors SEATTLE, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that the U.S. Food and Drug
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
Kodiak AI On Track for Year-End Driverless Long-Haul Launch as Autonomy Readiness Measure Jumps to 96% MOUNTAIN VIEW, Calif., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kodiak AI, Inc. (“Kodiak”) (Nasdaq: KDK), a leading provider of Physical AI-powered autonomous driving technology, today reaffirmed that it remains firmly on track to launch unsupervised driverless long-haul commercial service by the end of 2026. The company's Autonomy Readiness Measure ("ARM") for long-haul driverless operations reached
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
Turning Savings into Security: Canadians Feel on Track for Retirement, But Worry About What Comes Next BlackRock launches its first Canada Read on Retirement™ report, revealing new insights into the gap between Canadians' confidence today and concerns about their financial security in retirement BlackRock launches its first Canada Read on Retirement™ report, revealing new insights into the gap between Canadians' confidence today and concerns about their financial security in retirement
View source ↗ - Newszacks.com·53d ago·Neutral
Q3 Earnings on Track for 8th Consecutive Quarter of Double-Digit Growth The Q3 earnings season is shaping up to be the most broad-based growth performance in recent times, with 14 of the 16 Zacks sectors expected to enjoy higher earnings and six sectors producing double-digit growth.
View source ↗ - Newszacks.com·53d ago·Positive
Are Space ETFs on Track to Rally or Is It Just a Temporary Blip? Space ETFs are set to regain momentum as Starship succeeds and space investment surges, but volatility clouds the sector's outlook.
View source ↗ - Newsbarrons.com·54d ago·Negative
UniQure Insists Huntington's Drug Is Still on Track as Stock Plunges 48% UniQure says it still sees a path to regulatory approval for the drug candidate, AMT-130, even as the experimental gene therapy for Huntington's disease falls hort in a recent study.
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy Ernexa selected for the Emerging Track, recognizing the Company among emerging innovators in the cell and gene therapy sector
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
Moleculin Biotech Completes Enrollment in Part A of Phase 2/3 R/R AML MIRACLE Trial, Keeping Program on Track for Q1 2027 Data Readout HOUSTON, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company”) today announced that it has completed and closed enrollment in Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for the treatment of adults with relapsed or refractory acute myeloid leukemia (
View source ↗ - Newsnewsfilecorp.com·58d ago·Neutral
CEO.CA's Inside the Boardroom: Sixty North Gold on Fast-Track to Gold Mine Restart Toronto, Ontario--(Newsfile Corp. - September 25, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc. , is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience
View source ↗ - Newsfool.com·61d ago·Neutral
S&P 500 Profits Are on Track for a Third Straight Quarter of 25%+ Growth. The Index Hasn't Kept Up. FactSet pegs S&P 500 third-quarter earnings growth at 28.9%, which would be a third straight quarter of growth above 25%. From June 30 through FactSet's most recent report, the index's expected earnings for the next 12 months increased 8.8%, while its price rose just 1.8%.
View source ↗ - Newsglobenewswire.com·61d ago·Negative
Prospect Capital Management Featured in AdvisorHub Article on Firm's Four-Decade Track Record NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. (“Prospect”), investment adviser to Prospect Capital Corporation (NASDAQ: PSEC) and other funds, announced today that Prospect Capital Corporation's Chief Executive Officer, John Francis Barry III, and President and Chief Operating Officer, Grier Eliasek, were recently featured in an article published by AdvisorHub examining t
View source ↗ - Newsglobenewswire.com·61d ago·Neutral
Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome – First-Ever Fast Track Designation Granted for a Peeling Skin Syndrome Therapy – Second Fast Track Designation Granted to QRX003, in Addition to Netherton Syndrome – Fast Track Designation Facilitates Development and Expedites Regulatory Review of Therapies Addressing Serious Conditions with Significant Unmet Medical Need – Follows July 2026 FDA Clearance of the First-Ever IND S
View source ↗ - Newsglobenewswire.com·62d ago·Neutral
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution
View source ↗ - Newsbusinesswire.com·62d ago·Negative
PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS) BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced the successful completion of the End-of-Phase 1 (EOP1) mee
View source ↗ - Newsfool.com·63d ago·Negative
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within 2 to 3 Years. With Anthropic's Revenue Up 7-Fold This Year, Is That Timeline Still on Track? Anthropic's annualized revenue run rate is $65 billion, up from just $9 billion last year. CEO Dario Amodei said recently that AI is accelerating faster than he originally anticipated.
View source ↗ - Newsnewsfilecorp.com·65d ago·Neutral
Americas Gold and Silver Continues Track Record of Significant Discoveries at the Galena Complex with a New Galena Mine Vein Discovery Grading 1,062 g/t Ag, 0.7% Cu over 1.3 Meters While Crescent Drilling Returns 1,891 g/t Ag, 0.3% Cu over 1.3 Meters and 1,560 g/t Ag, 0.3% Cu over 1.1 Meters Toronto, Ontario--(Newsfile Corp. - September 18, 2026) - Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) ("Americas" or the "Company") a North American producer of silver and other cri
View source ↗ - Newsglobenewswire.com·68d ago·Negative
High Roller Technologies Launches Beta Version of ROLR™ Prediction Markets Platform; Commercial Launch on Track for October 2026 LAS VEGAS, Nevada, Sept. 15, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. ("High Roller" or the "Company") (NYSE: ROLR), a publicly traded online gaming and prediction markets company, today launched the closed beta of its ROLR™ prediction markets platform with a select group of invited participants. As announced on September 2, 2026, the invitation-only bet
View source ↗ - Newsfool.com·72d ago·Neutral
Exxon's 2030 Targets Call for $35 Billion More in Cash Flow. Here's the Milestone That Tells You It's on Track By 2028. ExxonMobil is a giant, integrated energy company. Although Exxon is making capital investments worldwide, one market is especially important to its 2030 target.
View source ↗ - Newszacks.com·74d ago·Positive
5 Stocks to Buy as U.S. Manufacturing Stays on Growth Track U.S. manufacturing stays on track, with lean inventories and solid production supporting Caterpillar, Kubota, Nordson and two other industrial stocks.
View source ↗ - Newsnewsfilecorp.com·75d ago·Neutral
Peruvian Metals on Track for Full Production for 2026 at the Aguila Norte Processing Plant and Reports Positive Sample Results from the Tailings Area Edmonton, Alberta--(Newsfile Corp. - September 8, 2026) - Peruvian Metals Corp. (TSXV: PER) (OTC PINK: DUVNF) ("Peruvian Metals" or the "Company") announces the completion of a major overall and maintenance program and the year-to-date production results for 2026 at its 80-per-cent-owned Aguila Norte processing plant ("Aguila Norte" or the "Plant")
View source ↗ - Newsfool.com·79d ago·Positive
Bill Ackman Says Pershing Square Has Achieved a 20% Gross Annual Return Since Inception and Aims to Keep Beating That Bar. Can His Newly Launched Funds Live Up to the Track Record? Bill Ackman's Pershing Square hedge fund has averaged a 20% annual return since 2004. His Pershing Square portfolio is highly concentrated.
View source ↗ - Newsglobenewswire.com·80d ago·Negative
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis Fast Track designation underscores the significant unmet need for patients with systemic sclerosis-associated Raynaud's phenomenon (SSc-RP), a debilitating manifestation affecting up to 90% of SSc patients No therapy is currently approved in the U.S. to treat SSc-RP and management options are limited and often inadequate for patients with more severe disease Liquidia plans
View source ↗ - Newsbenzinga.com·81d ago·Neutral
C3.ai Reports Strong Q1: Turnaround is On Track, CEO Says C3.ai (NYSE:AI) posted its fiscal 2027 first-quarter results after Wednesday's closing bell, beating estimates on the top and bottom lines. Here's a look at the details inside the report.
View source ↗ - Newszacks.com·81d ago·Positive
Is Ares Management on Track to Hit Its $750B AUM Target by 2028? ARES is progressing well to reach its $750 billion 2028 AUM target, backed by strong fundraising and rising fee-paying assets.
View source ↗ - Newsfool.com·81d ago·Positive
Gas Turbine Prices Are on Track to Nearly Triple. These Stocks Are Cashing In. Gas turbine prices have surged, boosting related stocks like GE Vernova. GE Vernova, the Global X MLP, and Energy Infrastructure ETF offer different risk/reward profiles for energy exposure.
View source ↗ - Newsprnewswire.com·82d ago·Neutral
Fendt™ Launches 1100 Vario™ MT Gen2 Track Tractor, Momentum™ 80-Foot Planter and 300 Vario Gen5 at 2026 Farm Progress Show Three groundbreaking products, including Fendt's first global tractor launch in the U.S., underscore the brand's commitment to the North American market. BOONE, Iowa, Sept.
View source ↗ - Newsglobenewswire.com·87d ago·Negative
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC) - Fast Track Designation follows encouraging Phase 1 data that were previously reported for R/R mCRC - - Potential Varseta-M monotherapy registrational study in R/R mCRC planned for initiation in 1H 2027 - SOUTH SAN FRANCISCO, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of mask
View source ↗ - Newsschaeffersresearch.com·89d ago·Negative
Dick's Sporting Goods Stock On Track for Worst Day Ever Dick's Sporting Goods (NYSE:DKS) is plunging 25.3% to trade at $134.03, after the sporting-goods retailer's fiscal second-quarter earnings and revenue fell short of Wall Street's targets.
View source ↗ - Newsseekingalpha.com·90d ago·Positive
VGMS: Multi-Sector Bond ETF By Vanguard, Vanilla Portfolio, Good Yield And Track Record VGMS is a diversified bond ETF, focusing on corporate bonds. The portfolio is roughly evenly divided between investment and non-investment grade, leaning short-term, with a duration of 3.7 years. Unlike most Vanguard funds, VGMS is active. It could and has outperformed its benchmark since inception, only since last year.
View source ↗ - Newszacks.com·94d ago·Positive
Will Comfort Systems' 47% Same-Store Growth Stay on Track in 2027? FIX's record backlog, technology demand and Modular expansion support strong growth, but tougher comparisons may slow momentum.
View source ↗ - Newsglobenewswire.com·94d ago·Negative
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis Designation reflects serious unmet need in idiopathic pulmonary fibrosis (IPF), where approved therapies slow but do not halt disease progression Actively enrolling patients in the RENEW Phase 2 trial evaluating LTI-03 in IPF; on track to report interim data in the second half of 2026 AUSTIN, Texas, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical
View source ↗ - Newsseekingalpha.com·95d ago·Positive
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction Journey Medical demonstrates strong Emrosi prescription growth, rebounding from Q1 lows with Q2 revenues up 23% to $18.5M and positive EBITDA. DERM's Emrosi franchise is gaining traction, with prescribers rising over 40% quarter-over-quarter and formulary coverage improving from 34% to 38%. Cost discipline is evident as SG&A declined and operating expenses rose less than 1%, while Emrosi's ASP and market penetrat
View source ↗ - Newsglobenewswire.com·96d ago·Negative
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN-101095, an oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins, in combination with pembrolizumab for the pot
View source ↗ - Newsglobenewswire.com·96d ago·Negative
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC SAN DIEGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines for the treatment of cancer, today announced that the U.S. Food and Drug Administration (F
View source ↗ - Newsbusinesswire.com·97d ago·Negative
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer AUSTIN, Texas--(BUSINESS WIRE)--Faeth Therapeutics (Nasdaq: FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of sapanisertib and serabelisib (PIKTOR) with pacli
View source ↗ - Newsglobenewswire.com·97d ago·Neutral
Bunker Hill Mining Announces First Stope Blast on Track for Commercial Production in Q4|2026 KELLOGG, Idaho and VANCOUVER, British Columbia, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to announce that the Company has completed the first production stope blast and has achieved four consecutive years without a lost-time incident, representing two significant milestones at the Company's 100% owned Bunker Hill Mine
View source ↗ - Newsseekingalpha.com·99d ago·Positive
Ategrity Specialty Insurance: With A Longer Track Record, Possible Multiple Expansion Ategrity Specialty Insurance Company Holdings has some appeal in that it trades at a meaningful P/B discount to possible comps. But it's a relatively new business, and there can be tail risks, so a greater track record may be needed for multiple expansion to be possible. There are also some related party considerations and possibly aggressive investments as far as the reserve portfolio is concerned, relating to
View source ↗ - Newsaccessnewswire.com·100d ago·Negative
Air T, Inc. Continues Track Record of Growth in First Quarter Fiscal 2027: Crestone Completes Acquisition of Arena MINNEAPOLIS, MN / ACCESS Newswire / August 14, 2026 / Air T, Inc. (NASDAQ:AIRT) today reported results for its fiscal 2027 first quarter ended June 30, 2026. Revenues totaled $115.5 million for the quarter ended June 30, 2026, an increase of $44.6 million, or 63%, compared to the same quarter in the prior fiscal year.
View source ↗ - Newsyoutube.com·100d ago·Neutral
OpenAI on Track to Double Revenue Ahead of IPO OpenAI is on track to generate more than $40 billion in annualized revenue, roughly double its run rate at the end of 2025, according to sources. Bloomberg's Rachel Metz explains how growth in paying ChatGPT users, enterprise adoption and coding assistant Codex are driving the surge, and why the enormous cost of computing power remains a key challenge for the AI company.
View source ↗ - Newsglobenewswire.com·100d ago·Neutral
Track Group Reports 3rd Quarter Fiscal 2026 Financial Results Key Third Quarter Data Points Revenue of $9.09 million, was roughly flat vs. $9.09 million last year.
View source ↗ - Newswsj.com·100d ago·Negative
U.S. Futures Fall; Gold on Track for Weekly Loss U.S. futures were lower after climbing in the previous session on soft inflation data that gave fresh hopes the Fed would hold interest rates at its meeting next month.
View source ↗ - News247wallst.com·101d ago·Positive
GAIQ's Track Record Matters More Than Its New ETF Wrapper, Here's Why Investors hunting for concentrated exposure to global innovation themes got a new option this summer when Guinness Atkinson launched the ETF share class of its long-running Global Innovators strategy.
View source ↗ - Newsseekingalpha.com·103d ago·Negative
i-80 Gold: Development On Track, And There Is A Lot Of Value In This Stock i-80 Gold is advancing five core Nevada assets, targeting a transition from developer to mid-tier producer with phased growth. Phase I production is on track for 150-200 Koz/year, with key catalysts including feasibility studies and first gold from Archimedes Underground in Q4. Recent financings have transformed liquidity, supporting project development and reducing balance sheet risk.
View source ↗ - Newsglobenewswire.com·104d ago·Neutral
Fast Track Successfully Unveils LAUNCHPAD at the Kuala Lumpur Media Event Event draws more than 500 attendees, offering media, industry partners, and fans a first look at a new platform that will come to life through a series of live showcase experiences across Southeast Asia Event draws more than 500 attendees, offering media, industry partners, and fans a first look at a new platform that will come to life through a series of live showcase experiences across Southeast Asia
View source ↗ - News247wallst.com·104d ago·Negative
Amazon's New Texas Data Center On Track To Be Biggest Polluter In America In rural West Texas, land-clearing crews are preparing a site for what could become the single largest source of carbon dioxide emissions among American power plants.
View source ↗
Insider trading
Open-market buys and sells by TRCK officers and directors.
- Bought
- $331k
- Sold
- —
3 trades
0 trades
- Jcp Investment Management, Llcbought
- Sehnaoui Karimbought
- Sehnaoui Karimbought
97 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in TRCK.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
